ACCC would like to recognize the 2022 National Oncology Conference Task Force members for their extraordinary effort and commitment in developing the program of the ACCC 39th National Oncology Conference.
Dr. Zinkeng Asonganyi (aka “Dr Z”) oversees all facets of ambulatory practice at the University of Texas Medical Branch, including retail and specialty pharmacy services, outpatient infusion, and the integration of pharmacists into ambulatory clinics. Prior to this role, Dr. Asonganyi served as the senior pharmacy manager at Anne Arundel Medical Center (Luminis Health) in Annapolis, Maryland, overseeing the oncology department, investigational drug services, and outpatient pharmacy operations, including the development of a specialty pharmacy business. Dr. Asonganyi is an active participant in the American Society of Health System Pharmacists (ASHP) and several local pharmacy organizations.
Dr. Asonganyi is a 2012 graduate of the University of Findlay College of Pharmacy in Ohio, and he has been a health system pharmacy administrator for most of his career. He is passionate about controlling pharmaceutical expenses through supply chain and formulary management as well as revenue cycle management for both medical and pharmacy benefits.
Matt Manning is a radiation oncologist in Greensboro, North Carolina, with broad experience in community oncology, clinical research and advocacy. Manning earned his degree in chemistry at The College of William and Mary and completed his medical school and residency at the VCU School of Medicine.
Manning joined Cone Health in 2001, implementing advanced technology such as IMRT, SRS and SBRT. He served as the Medical Director of Stereotactic Radiosurgery and Medical Director of Radiation Oncology. He also served as the Cone Health Chief of Oncology, leading radiation and medical oncology for six cancer campuses from 2019 through 2021.
Manning has served on the Clinical Affairs and Quality Committee for ASTRO. Previously, he was a member of the ASTRO Congressional Relations Subcommittee. During residency, he was elected Chairman of the Executive Committee for the Association of Residents in Radiation Oncology (ARRO). He was named a Fellow in ASTRO in 2019.
Manning is committed to successful community cancer research. In the past three years, he has co-authored over twenty articles published in the Journal of Clinical Oncology, Journal of Applied Clinical Medical Physics, the “Red Journal” and mainstream media.
In 2016, Manning’s project to drastically reduce costs in oncology received the ACCC Innovator Award. The project focused on “Hotspotters.” He showed that costs are less driven by expensive cancer treatment and result from gaps in coordination of services in medically complex patients. Manning is active with his hospital’s Next Generation ACO, having served as the Oncology Division Chief and Operating Committee member.
Manning is a member of the Greensboro Health Disparities Collaborative. GHDC conducted ACCURE. This study was successful in eliminating racial disparity in cancer care.
Manning is board-eligible in Clinical Informatics. He has served on the EPIC Oncology and Radiation Oncology Steering Committees.
Manning is a past President of the Greater Greensboro Society of Medicine and has served on the ASCO Membership Committee.
Manning and his wife Allison have three daughters. He loves dragging their suitcases through airports, playing music and walking his dogs.
Anne Marie Rainey, RN, MSN, CHC, is the Director of Quality and Value-Based Care
at Clearview Cancer Institute in Huntsville, Alabama. She has previous experience in government quality reporting as a contractor for the Centers for Medicare & Medicaid Services (CMS) and the Centers for Disease Control and Prevention (CDC).
After obtaining her Master of Nursing in Clinical Leadership and Administration, Rainey transitioned to the community oncology setting. Her work interests include quality metrics analysis, program implementation, health policy, and advocacy for community oncology.